ARWR
ARWR
NASDAQ · Biotechnology

Arrowhead Pharmaceuticals In

Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks
$79.71
-0.19 (-0.24%)
As of Jun 24, 7:51 PM ET ·
Analyst Consensus
Strong Buy
20
Analysts
High
Coverage
Buy 17 85%
Hold 3 15%
Sell 0 0%
Price Target
Analyst Price Target -12.8% upside
Low Target $62.98
Average Target $69.50
High Target $88.85
Current Price $79.71
Current
$79.71
Target
$69.50
$62.98 $69.50 avg $88.85
Scenario Analysis
Bear Case
$62.98
-21.0%
Low target
Base Case
$69.50
-12.8%
Avg target
Bull Case
$88.85
+11.5%
High target
Risk/Reward
0.5x
Unfavorable
Price in Context
52-Week High
$84.55
-5.7% from high
52-Week Low
$14.30
+457.4% from low
50-Day SMA
$66.84
+19.3% vs SMA
200-Day SMA
$36.65
+117.5% vs SMA
RSI (14)
36.5
Neutral
Target vs 52W High
$69.50
-17.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +9.6%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -45.9%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +188.1%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -8.5%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.7%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -65.9%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -32.0%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -45.4%